Eliana Ruggiero
Overview
Explore the profile of Eliana Ruggiero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1046
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Musella M, Guarracino A, Manduca N, Galassi C, Ruggiero E, Potenza A, et al.
Nat Immunol
. 2024 Sep;
25(11):2166.
PMID: 39289560
No abstract available.
2.
Noviello M, De Lorenzo R, Chimienti R, Maugeri N, De Lalla C, Siracusano G, et al.
Front Immunol
. 2024 Aug;
15:1381091.
PMID: 39136010
Introduction: SARS-CoV-2 pandemic still poses a significant burden on global health and economy, especially for symptoms persisting beyond the acute disease. COVID-19 manifests with various degrees of severity and the...
3.
Spiga M, Martini E, Maffia M, Ciceri F, Ruggiero E, Potenza A, et al.
Semin Immunopathol
. 2024 Jul;
46(3-4):8.
PMID: 39060547
Adoptive cell therapy (ACT) using Chimeric Antigen Receptor (CAR) and T Cell Receptor (TCR) engineered T cells represents an innovative therapeutic approach for the treatment of hematological malignancies, yet its...
4.
Cianciotti B, Magnani Z, Ugolini A, Camisa B, Merelli I, Vavassori V, et al.
Front Immunol
. 2024 Mar;
15:1315283.
PMID: 38510235
Background: In adoptive T cell therapy, the long term therapeutic benefits in patients treated with engineered tumor specific T cells are limited by the lack of long term persistence of...
5.
Giovenzana A, Bezzecchi E, Bichisecchi A, Cardellini S, Ragogna F, Pedica F, et al.
iScience
. 2024 Feb;
27(3):109032.
PMID: 38380252
Obesity is characterized by the accumulation of T cells in insulin-sensitive tissues, including the visceral adipose tissue (VAT), that can interfere with the insulin signaling pathway eventually leading to insulin...
6.
Casucci M, Bonini C, Ruggiero E
Nat Immunol
. 2024 Jan;
25(1):4-6.
PMID: 38168961
No abstract available.
7.
Musella M, Manduca N, Maccafeo E, Ruggiero E, Sistigu A
Methods Mol Biol
. 2023 Dec;
2748:13-28.
PMID: 38070104
A cardinal principle of oncoimmunology is that cancer cells can be eliminated by tumor-infiltrating cytotoxic CD8 T lymphocytes. This has been widely demonstrated during the last 20 years and also...
8.
Manfredi F, Stasi L, Buonanno S, Marzuttini F, Noviello M, Mastaglio S, et al.
Sci Adv
. 2023 Dec;
9(48):eadg8014.
PMID: 38039364
To study and then harness the tumor-specific T cell dynamics after allogeneic hematopoietic stem cell transplant, we typed the frequency, phenotype, and function of lymphocytes directed against tumor-associated antigens (TAAs)...
9.
Tassi E, Bergamini A, Wignall J, SantAngelo M, Brunetto E, Balestrieri C, et al.
Front Immunol
. 2023 Oct;
14:1212444.
PMID: 37868997
Introduction: Despite predicted efficacy, immunotherapy in epithelial ovarian cancer (EOC) has limited clinical benefit and the prognosis of patients remains poor. There is thus a strong need for better identifying...
10.
De Monte L, Clemente F, Ruggiero E, Pini R, Ceraolo M, Schiavo Lena M, et al.
EBioMedicine
. 2023 Sep;
97:104819.
PMID: 37776595
Background: Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis and it is characterized by predominant pro-tumor Th2-type inflammation. T follicular helper (Tfh) cells are relevant immunoregulators in cancer, and often...